| Hosting Organization |
 |
 |
| Operating Organization |

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Lifesciences, Inc. |
| Supporting Organization |
 |
| International Marketing Partner |
 |
|
Participants List
(Academia) |
National Yang-Ming University, Taiwan
Abyad Medical Center and Middle-East Longevity Institute, Lebanon
Akershus University Hospital, Norway
Aligarh M University, India
American University of Beirut, USA
Antwerp University Hospital, Belgium
Applied Proteomics and Molecular Medicine, USA
Aristotelian University of Thessaloniki, Greece
Banaras Hindu University, India
Barrow Neurological Institute, USA
Baylor College of Medicine, USA
Ben-Gurion University of the Negev, Israel
Boston University School of Medicine, USA
Cancer Research Technology, UK
CHDI Foundation, California
Chinese Academy of Sciences, China
CRG-Centre de Regulaci Genmica, Spain
CSIRO Molecular and Health Technologies, Australia
Duke University, USA
Emory University, USA
exas Southern University, USA
Florida A&M University, USA
Global Pathology Support, The Netherlands
Gujarat AIDS Awareness and Prevention Unit, India
Haematopoietic Stem Cell Laboratory, UK
Harvard Medical School, USA
Hospital S Hospital S Joao, Portugal
Human BioMolecular Re-. search Institute, USA
Indiana University School of Medicine, USA
Indiana University School of Medicine, USA
Innsbruck Medical University, Austria
Institute of Experimental Pharmacology, Slovak
Instituto De Biologia Experimentale Tecnologica, Portugal
Karolinska Institutet, Sweden
Keystone College Academia, USA
McGill University, Canada
Mercer University, USA
National Center for Toxicological Research, USA
National Institutes of Health, USA
Netherlands Cancer Institute, The Netherlands
New York Medical College, USA
Osaka University, Japan
Paul-Ehrlich-Institute, Germany
Penn State College of Medicine, USA
Pennsylvania State University College of Medicine, USA
Pharmacology Temple University, USA
Scientific Advisory Board Tolerx, USA
Shanghai Unviversity of Traditional Chinese Medicine, China
Solid Tumor Working Party, Italy
Stanford University, USA
Structural Genomics Consortium Karolinska Institutet, Sweden
Tabriz University of Medical Sciences, Iran
Technion - Israel Institute of Technology Rappaport Institute, Israel
The Babraham Institute, UK
The Hebrew University, Israel
The Institute of Cancer Research, UK
The University of Queensland, Australia
The University of Sydney, Australia
The University of Texas, USA
UC College of Medicine, USA
Universidade Federal Fluminense, Brazil
University Clinic Bonn, Germany
University of Basel, Switzerland
University of British Columbia, Canada
University of California, USA
University of California-San Francisco, USA
University of Camerino, Italy
University of Cape Town, USA
University of Colorado Health Sciences Center, USA
University of Crete, Greece
University of Geneva, Switzerland
University of Heidelberg, Germany
University of Hong Kong, China
University of Maryland School of Pharmacy, USA
University of Maryland, USA
University of Massachusetts Medical School, USA
University of Miami School of Medicine, USA
University of Miami, USA
University of Miami, USA
University of Oklahoma Health Sciences Center, USA
University of Siena, Italy
University of Southern Denmark, Denmark
University of Texas at Dallas, USA
University of Texas Health Science Center, USA
University of Texas Medical, USA
University of the Sciences in Philadelphia, USA
University of Utah School of Medicine, USA
University of Western Australia, Australia
Utah State University, USA
Virginia Commonwealth University, USA
University of Gothenburg, Sweden
|
Participants List
(Business) |
3 P Biopharmaceuticals, USA
Abbott Laboratories, USA
Adolor Corporation, USA
Affimed Therapeutics AG, Germany
AILERON Therapeutics, USA
Algorithme Pharma Inc., Canada
Allon Therapeutics Inc., USA
Alpha Cancer Technologies Inc., USA
Alpha-2 Pharmaceutica AB, Israel
Amgen, Inc., USA
Arena Pharmaceuticals, USA
Astellas Pharma Inc, Japan
Astellas Pharmaceutical Inc., Japan
AstraZeneca Pharmaceuticals, USA
AstraZeneca R&D Molndal, Sweden
Astrazeneca R&D Sodertolje, Sweden
AstraZeneca, UK
AstraZeneca, USA
AuxoCell Laboratories, Inc., USA
Avexa Ltd, Australia
Bayer HealthCare, USA
Bayer Schering Pharma AG, Germany
BellBrook Labs, LLC, USA
Biological Mimetics, Inc., USA
BioPerspectives, USA
Biota Holdings Limited, USA
Boehringer Ingelheim Pharmaceuticals, Inc., USA
Bristol-Myers Squibbs, USA
Centocor/Johnson & Johnson, USA
Chemistry Forma Therapeutics, Inc., Singapore
Coley Pharmaceutical GmbH, Germany
Cordex Pharma, Inc., USA
Cornerstone Pharmaceuticals, USA
Covidien, USA
Daiichi Sankyo Pharma Development, Japan
deCODE Chemistry, USA
DxS Ltd, USA
Eisai Co., Ltd., Japan
Elan Pharmaceuticals, USA
Europe GlaxoSmithKline R&D, UK
Genentech, USA
Genetix Ltd, UK
genscript, USA
Genzyme Pharmaceuticals, USA
Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA
Hoffmann-La Roche, Switzerland
ICON PLC, USA
IDDC Corporation, USA
Idera Pharmaceuticals, USA
Jesus College, England
Johnson & Johnson Pharmaceutical, USA
Johnson & Johnson Research Pty Limited, Australia
Laboratory Cellular Technology Ltd., USA
Lundbeck Research, USA
Mallinckrodt, Inc., USA
MDS Pharma Services, USA
Medimmune, UK
Merck & Co. Inc, USA
Merck & Co., Italy
Merck and Co., Inc., China
Merck KGaA, Germany
Merck Research Laboratories, USA
Nerviano Medical Sciences, Italy
Novartis Institutes for Biomedical Research, USA
Novartis Institutes, Switzerland
Novartis Pharmaceuticals Corporation, USA
Novartis, China
Ocimum Biosolutions, India
Ondokuz Mayis University, Turkey
OphthalmoPharma, Switzerland
Pfizer, USA
Pharmanet Development Group, Inc., USA
PharmaNet, Inc., USA
Ranbaxy Laboratories Limited, India
Reaction Biology Corporation, USA
RegPak BioPharma Consulting, The Netherlands
Sanofi Aventis, USA
Schering Plough Research Institute, USA
Schlich & Co, UK
Scott & White, USA
Sequoia Pharmaceuticals Inc., USA
SeraCare Life Sciences, USA
Shanghai Biochip Co., Ltd, China
Shenogen Pharma Group, China
Siena Biotech S.p.A. A company, USA
Simulations Plus, Inc., USA
Synta Pharmaceuticals Corp, USA
TEVA Pharmaceuticals, USA
The Takeda Oncology Company, USA
ThromboGenics, USA
Transgene, France
US Oncology Research, Inc., USA
Vaxinnate, USA
Wyeth Research, USA
XOMA (US) LLC, USA
Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland
Zhejiang Hisun Pharmaceutical Co., Ltd, China
Tehran University of Medical Sciences , Iran
|
|
 |
|
 |
WCG 2009
(December 1-7, 2009, Foshan, China) |
 |
ICC 2009
(Dec. 5-7, 2009, Shanghai, China) |
 |
ICA 2010
(March 24-26, 2010, Beijing, China) |
 |
WCV 2010
(March 24-26, 2010, Beijing, China) |
 |
SEB 2010
(Apr. 22-24, 2010, Shanghai, China) |
|
|
|
| |
|
NO.1
GL Biochem (Shanghai) Ltd.
GL Biochem (Shanghai) Ltd. is a leading manufacturer of peptides、peptides reagents、 building blocks and antibody and has the most diverse in-house made product line in China.
Since our inception in 1998, GL Biochem has been experiencing tremendous growth as a world leading producer of custom peptides. Among nearly 1000 dedicated GL employees, about 360 chemists are directly involved in peptide synthesis, with additional 90 technicians in HPLC purification. GL Biochem already has the biggest custom peptide synthesis capacity in the world with 10000 research grade peptides per month production scale.
NO.2
Viva Biotech Ltd.
Viva Biotech, a Contract Research Organization (CRO), is dedicated to providing drug discovery biology service to global pharmaceutical and biotech companies.
Viva has a team of leading scientists in drug discovery industry, many with over 10 years pharmaceutical and drug discovery experience in senior positions within companies such as Pfizer, Charles River, Millennium, Arqule, Enanta, and Abbott, and at premier academic institutions such as Harvard, Stanford, Cornell, Duke, Hughes Institute and the Burnham Institute.
With our experienced team and efficient technology platforms, Viva is your partner for increasing efficiency and cutting the cost of drug discovery. Viva, with strong financial backing, is strategically located in the world-renowned biotech and pharmaceutical base, Zhangjiang high-tech industrial park, Shanghai, China.
Viva aims to provide biology focused services supporting drug discovery and deliberately has no internal drug discovery activities to avoid any conflict of interest with its clients.
NO.5
BGI Shenzhen
The Beijing Genomics Institute (BGI) was founded in Beijing on Sept 9th, 1999 with the mission of supporting the development of science and technology, building strong research teams, and promoting the development of commercial scientific services.
With a goal toward excellence, high efficiency, and accuracy, BGI has successfully completed a large number of projects. These include sequencing 1% of the human genome for the International Human Genome Project, contributing 10% to the International Human HapMap Project, carrying out research to combat SARS, being a key player in the Sino-British Chicken Genome Project, and completely sequencing the rice genome, the silkworm genome, and, most recently, the first Asian diploid genome. In conjunction with carrying out these projects, BGI has established its own technical platforms based on large-scale genome sequencing, efficient bioinformatics analyses, and innovative genetic health care initiatives. These distinguished achievements have made a great contribution to the development of genomics in both China and the world, and have established BGI as a world-class research institution. In aiming for and attaining these goals, BGI has become the number one genomics institute in Asia and the third largest genomics institute in the world.
NO.7
Cambridge Crystallographic Data Centre
The Cambridge Crystallographic Data Centre (CCDC) provides invaluable structural knowledge to the scientific community, both for academic research, teaching and the pharmaceutical and chemical industries. A registered charity and not-for-profit organisation, CCDC curates the ever growing database of small molecule experimental crystal structures, the Cambridge Structural Database (CSD). With over 40 years of scientific expertise, the CCDC’s software and database tools benefit a broad spectrum of users in research, development, cheminformatics, bioinformatics and teaching.
NO.8
Shanghai Wellson Biotech Co., Ltd.
Founded in 2000, DiscoveRx is a company headquartered in California with offices in England, Germany, and France. DiscoveRx is dedicated to the development and commercialization of innovative solutions for discovery research. DiscoveRx assay solutions are based on our core proprietary Enzyme Fragment Complementation (EFC) technology that is well established in clinical diagnostics and now further enhanced to provide unique solutions to drug discovery research. EFC technology is a proven, established screening technology in most major pharmaceutical companies and our EFC-based HitHunter™ cAMP assays are the market leader in GPCR screening applications. PathHunter™ technology, an adaptation of EFC technology, is an innovative and comprehensive assay system that enables live cell-based assays for pathway profiling and screening. Through our core HitHunter™, PathHunter™, and EFC technologies, DiscoveRx is able to offer assay solutions for every major class of drug target, including GPCRs, kinases, proteases, nuclear hormone receptors, transcription factors, and secreted proteins. DiscoveRx remains committed to fully exploit the commercial potential of its EFC technology either solely or with its corporate partners. DiscoveRx has partnerships with leading life sciences organizations, such as, Merck,GlaxoSmithKline,Roche,Schering Plough,Janssen, and co-marketing with Caliper Life Sciences for our PathHunter eXpress products. DiscoveRx values such patnerships and is actively seeking additional collaborative alliances to commercialize and provide early access to new technology platforms in the drug discovery and development markets.
NO.9
Araclon Biotech, S.L.., Spain
Araclon Biotech is a private company devoted to research and development of therapies and diagnostic methods for degenerative diseases, with a special emphasis on Alzheimer’s disease (AD).
The company’s objectives are the international commercialization of a highly sensitive blood test to help physicians to diagnose AD and the development of an effective therapy against AD.
Araclon Biotech´s ABtest® ELISAs are colorimetric assays to discriminate between Alzheimer Disease, Mild Cognitive Impairment and non demented individuals. They are supported by fully developed and simple to use protocols. Many medical and research & development laboratories will be able to work with them.
The company is currently open for partnership to worldwide bring the product to the market.
NO.10
AstaTech(Chengdu)Pharmaceutical Co., Ltd.
AstaTech Chengdu is a wholly owned subsidiary of AstaTech, Inc. (USA). The company was established in 2001 in Chengdu's Hi-tech Development Zone. It serves as AstaTech, Inc.'s Chinese R&D base. AstaTech Chengdu's primary activities area, key intermediate custom synthesis and new product development. AstaTech Chengdu specializes in chiral technologies such as asymmetric synthesis and enzyme-assisted synthesis.
NO.11
Genscript Corporation
GenScript is dedicated to serving pharmaceutical, biotech, and academic customers in the areas of drug discovery, development and life science research. With a global presence and local access, GenScript provides high-quality biology CRO services and around-the-clock account support to our customers all over the world.
NO.12
Colorcor China
Colorcon is a global company that develops, manufactures and supplies specialty chemicals and excipients for the pharmaceutical industry. Our core business is the design and technical support of advanced coating systems for pharmaceutical dosage forms for immediate, sustained and enteric release. In addition, the company's technological capabilities include assistance in the development of solid dosage formulations. Colorcon, Inc. is a global Leaders in Pharmaceutical Technology,We have positioned our business offices, manufacturing facilities and technical service laboratories in strategic locations around the world. This global network ensures the fast, timely access to the products and services that customers demand today.
As an industry leader, Colorcon also makes a point of sharing its expertise through a variety of ongoing educational courses, seminars and symposiums. To help our customers succeed in the highly competitive and increasingly global pharmaceutical market. Our best-of-class technologies are complemented by our values-added services,including technical service,global regulatory information and independent research support.
NO.13
IDEX Health & Science
IDEX Health & Science manufactures Innovadyne high precision, non-contact, liquid-handling instrument platforms; the Nanodrop, Screenmaker, and Platemaker for Drug Discovery, Genomics, and Proteomics. These easily integrated devices are used in laboratories worldwide for HTS, Assay Development, Protein Crystallography, PCR, sequencing, and MALDI applications and come with easy-to-use, state-of-the-art .NET software.
NO.14
Founder International Inc.
Founder International is a wholly-owned subsidiary of Founder Group which was established in 1986, as one of the most significant IT solution providers in China. Founder International has committed to technological innovation and continued to play a vital role in the IT research & development landscape.
Life Science Informatics (LSI) of Founder International is a professional bioinformatics and cheminformatics solution provider. We create values for customers in the industry of CRO, Pharmaceuticals, Chemicals and Life Science Research Institutes with the innovative ideas, as well as providing customized development and consulting service.
It is more cost-effective to introduce specialized information management applications in Life Science industry, instead of the traditional paper work and office automation tools for R&D and project process management. With sophisticated bio-chemists, experienced software engineers and solid foundation of Founder’s IT research & development capabilities, LSI is able to develop the cutting-edge customized Bioinformatics & Cheminformatics systems, which are integrated with the overseas partners’ technologies (CLCbio, ChemAxon & Agilent), and based on chemical structure edition, searching, sorting, genomics/DNA/RNA/Protein analysis & research and electronic laboratory notebook, etc. LSI of Founder International, as China’s leading Bio- & Chem-informatics service provider, is bringing versatile Life Science Informatics Solutions, and delivering best value to you.
NO.15
LABCHINA CO., LIMITED
LabChina Co., Ltd. was established in 2003 and specializes in the distribution of top end laboratory equipment and consumables to the research and industrial markets.
Our head office is in Guangzhou and we have branches in Beijing, Shanghai, Xian, Hong Kong. We have an office in Taipei to service the Taiwan market. Our sub-branches are situated in Shenzhen, Wuhan, Changsha, Fuzhou, Hangzhou and Nanjing and we also work through an extensive network of sub-distributors effectively covering the whole of the PRC.
All the product we sell are backed by full service and technical support. LabChina is the exclusive distributor for Biospacelab imaging systems for the PRC and Taiwan. This product range consists of state of the art, radio active and non radioactive imaging instruments, some with patented features. Some application fields of these products include pharmacokinetics, cancer research, medicine, cosmetology, environmental/ biodiversity, infectious disease, stem cell, genomics, neuroscience and cardiovascular research, to name a few.
We stand by our motto “Only our customers are better than our products”
NO.16
CHINA-JAPAN FEID UNION CO., LTD.
With 22 studies conducted, Tian Xian Liquid is proved it can regulate immune system, suppress the growth of cancerous cells, prevent re-occur and metastasis, suppress cancer stem cells, multi-target and reversion of multi-drug resistance, as a good supplement to helpful auxiliary with general treatments.
NO.17
Quantum Design Scientific Instrumentation Trading (Beijing) Co., Ltd.
Quantum Design is a privately held corporation that develops and markets advanced technology systems and instruments. Worldwide, Quantum Design has become the leading commercial source for integrated laboratory analytical systems. With the QD-LOT merger in 2007, Quantum Design established its strong branches in most of European countries. Since then, together with its strong European subsidiaries, Asian subsidiaries, Quantum Design is creating a global network offering distribution and after-sales service to manufacturers of scientific and industrial equipments.
Products in Biological Area: Automated Patch Clamp, Cell Metabolic Activity Analyzing System, CO2 Microscope Incubators; Microfluidics Platform ; Desk-top SEM; Desk-top Stemcell division system
NO.18
Simulations Plus, Inc.
Simulations Plus is a leading developer of simulation and modeling software for the pharmaceutical industry. We currently offer four products for pharmaceutical research: ADMET Predictor™, ClassPharmer™, DDDPlus™, and GastroPlus™.
ADMET Predictor predicts a variety of properties of chemical compounds from their molecular structures and has been ranked #1 in every comparison study with other commercial predictive software. Integrated into ADMET Predictor is ADMET Modeler, which creates the predictive models. This advanced, proprietary program includes state-of-the-art technologies for machine learning.
ClassPharmer generates classes of molecules based on the largest common set of connected atoms (“scaffold”) in each class. Recent additions to ClassPharmer have moved it into the realm of a molecule design tool, accomplished via integration of algorithms that generate new molecular structures with ADMET Predictor to evaluate the new structures.
DDDPlus simulates how tablets and capsules disintegrate and dissolve during in vitro dissolution experiments.
GastroPlus, the company’s flagship product, simulates absorption, pharmacokinetics, and pharmacodynamics of potential new drugs. Its powerful PBPK simulations enable researchers to predict the amount of drug that reaches different body tissues and organs. Its ability to deal with a variety of oral dosage forms and controlled release capabilities is unmatched.
Simulations Plus also provides consulting services.
NO.19
Gene Company Limited
Gene Company Limited was founded in August 1992 in Hong Kong by a group of enthusiastic biotechnologists. Our scope of business can be categorized into two main areas; (a) distribution of full range molecular and cell biology instrumentation, reagents and consumables; and (b) consultation services on research projects and experimental techniques. By Now, Gene prides itself as being one of the leading distributors for biotechnology products,e.g. Affymetrix, Applied Imaging, Corbett Research, Dako, Li-Cor and Biotage and has successfully become one of the major research product suppliers to major genomics, proteomics, biochip and stem cell research centres in China. Gene is a wholly-owned subsidiary of Gene Group Holdings Limited in Hong Kong. Apart from distribution activities, the Group is also engaged in biotech products R&D and manufacturing, as well as Traditional Chinese Medicine (TCM) technology development.
NO.20
Promega (Beijing) Biotech Co., Ltd.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about
Promega, visit www.promega.com.
NO.21
SAGE Publications, Inc.
SAGE is one of the leading publishers of humanities, social sciences and STM journals. SAGE continues to be privately and independently
owned and we have 4 regional offices globally.
SAGE publishes well known journals such as the American Journal of Sports Medicine, Urban Studies, Journal of Composite Materials,
Journal of Communication Research, Neurorehabilitation & Neural Repair, The Counseling Psychologists, Social Studies of Science,
Crime & Delinquency amongst others.
SAGE Asia-Pacific was established in September 2006 in Singapore and we have 4 regional offices throughout Asia-Pacific. SAGE Asia-Pacific
journal team focuses on ensuring that our e-content reaches most researchers, graduates and undergraduates. We also welcome opportunities
to explore other partnership arrangements such as publishing journals, translating our content etc.,
SAGE works towards ensuring all experiences with us would be a satisfactory and rewarding one.
Company website: www.sagepublications.com <http://www.sagepublications.com >
NO.22
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
Shanghai Hengrui Pharmaceuticals Co., Ltd is a fully integrated drug discovery company dedicated to discovery of New Chemical Entities (NCEs).
We have many scientists in all areas of drug discovery: Synthetic organic chemistry, Medicinal chemistry, Parallel chemistry, Analytical chemistry, Assay development, Screening operation, Chemo/Bio Informatics, Molecular biology, Cell biology, Protein purification, Animal modeling, BMPK, Toxicology, Formulation/Pre-formulation, QA/QC and Preclinical development.
We are conveniently located in Minhang Economic Zone, 30 minutes from the vibrant Shanghai downtown and occupy a new 20000 square meter laboratories equipped with state-of-art instruments.
NO.23
MicroConstants China Co., Ltd.
MicroConstants is a global leader in providing high quality DMPK and bioanalytical contract services to pharmaceutical and biotech companies worldwide. MicroConstants have ten years history of USFDA and OECD GLP compliance and have provided GLP bioanalytical support for over 500 drugs. MicroConstants have been successfully audited twice by USFDA.
Our services include: Bioanalytical method development/validation (ELISA, LC/MS/MS); Sample bioanalysis under FDA and OECD guidelines; GLP formulation analysis; DMPK studies; Toxicokinetics studies; Project management for toxicology and clinical studies.
NO.24
DL Instrument, Inc.
DL Instruments, Inc. is the leading provider of automated and traditional patch clamp devices in China. We also provide other electrophysiological devices and imaging, animal behavior instruments. We represent a wide range of quality products manufactured by many of the world’s leading companies in the life science field, such as HEKA, Sophion, Sutter, etc. Our sales team consists of more than 20 experienced sales engineers in China. We have at least two training courses for patch clampers in China every year. We have a strong technical support group to help our customers with any problems. We pride ourselves on the excellence of our after-sale service.
|
|